12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Company News  |  Other News

GlaxoSmithKline, Institute of Cancer at Barts, Queen Mary, University of London proteomics, inflammation news

The institute and the university spun out their cell signaling pathway technology into newco Activiomics Ltd. Activiomics will use its Targeted In-depth Quantification of...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >